Seizures Associated with High Maprotiline Serum Concentrations
- 1 November 1983
- journal article
- case report
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 28 (7) , 555-556
- https://doi.org/10.1177/070674378302800710
Abstract
Maprotiline is a tetracyclic antidepressant which appears to have accounted for a relatively large proportion of the seizures associated with antidepressant use. The literature proposes two mechanisms of seizure induction: interaction with other medications and concomitant medical conditions lowering the seizure threshold. Observations during a study of maprotiline blood levels suggest that elevated serum concentrations achieved with therapeutic doses may also be linked to the seizure-induction mechanism. Monitoring of maprotiline blood levels may help to identify patients at risk.Keywords
This publication has 8 references indexed in Scilit:
- Grand mal seizures induced by maprotilineAmerican Journal of Psychiatry, 1982
- Maprotiline hydrochloride and convulsions: a case reportAmerican Journal of Psychiatry, 1982
- Plasma levels and tricyclic antidepressant therapy: Part 2. Pharmacokinetic, clinical and toxicologic aspectsBiopharmaceutics & Drug Disposition, 1980
- ANTIDEPRESSANTS AND CONVULSIONSThe Lancet, 1979
- Maprotiline hydrochloride and grand-mal seizures.BMJ, 1978
- Estimation of maprotiline in serum by gas-chromatography, with use of a nitrogen-specific detector.Clinical Chemistry, 1977
- Benzodiazepines and Tricyclic Antidepressant Plasma LevelsBMJ, 1973
- INDIVIDUAL DIFFERENCES IN THE PHARMACOKINETICS OF MONOMETHYLATED TRICYCLIC ANTIDEPRESSANTS: ROLE OF GENETIC AND ENVIRONMENTAL FACTORS AND CLINICAL IMPORTANCE*Annals of the New York Academy of Sciences, 1971